Legendary Stock-Picker Predicts Best-Performing Stock of 2020

Jeff Brown 4X Window: FREE Penny IPO Recommendations Event

Jeff Brown 4X Window is a free special presentation by Jeff Brown where he’ll reveal one tech subsector with some of the biggest profits on offer. His first recommendation of one of these stocks – what he calls “Penny IPOs” – gave readers the chance at gains of 432% in just 41 trading days.

Folks who’ve been following us know one of the profit trends we’re most excited about is the rapid innovation underway in the tech sector.

That’s why today, we bring you insight from tech expert and Silicon Valley insider, Jeff Brown. Below, he shares two warning signs that a company isn’t worth your investment.

And on Wednesday, September 23, at 8 p.m. ET, he’s hosting a free special presentation to reveal one tech subsector with some of the biggest profits on offer. His first recommendation of one of these stocks – what he calls “Penny IPOs” – gave readers the chance at gains of 432% in just 41 trading days.



GET FREE 3-day Video Trading Series Showing You How to Start Making an Extra $1,000 a Month.


By Jeff Brown, Editor,  The Bleeding Edge

I’m an optimist by nature.

As my longtime readers know, I believe we are on the verge of an age of abundance. The companies and technologies that drive this age will focus on trends like 5G wireless networks, precision medicine, artificial intelligence, cloud computing, quantum computing, and the next generation of clean energy production – nuclear fusion.

But we have to be realistic. Not all technology companies are great investments. In fact, even great technology companies can be bad investments. And I predict we’re on the verge of a “splintering” in the market.

What does that mean? COVID-19 has ushered in a new economic environment. Companies whose products and services are well-positioned for this new environment are absolutely booming. And those that aren’t are suffering badly. The next two years will be brutal for companies that don’t adapt quickly.

This splintering will send a small segment of the tech world – one that was largely ignored until the pandemic – much higher.

The pandemic pulled forward some tech trends by 5-10 years. For example, we’ve been talking about teleworking for the last 20 years. But what happened?

Organizations and their management teams became even more centralized, and urban centers grew. Companies and managers were reluctant to have their workforces go remote. After all, managers felt they couldn’t control and manage their employees if they couldn’t “see” what they were doing all day long.

But now they’ve been forced to let employees work remotely. In March, estimates showed almost 6 out of every 10 Americans were working from home. And this trend will persist even after the pandemic passes.

For instance, Pinterest forked over nearly $90 million to break its contract on a San Francisco office complex. It won’t need the space in a remote work environment.

Or consider e-commerce. Earlier this year, many online retail categories showed a 74% increase in online orders immediately following the economic lockdowns. And now that consumers understand how convenient these services are, there will be no turning back.


The firm that called the EXACT PEAK of the Dot-Com boom
has just issued another major prediction.

If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead…

Watch the Video

Let’s consider one more example. Earlier this year, Nokia released data saying that most wireless networks around the world see 30-45% growth in traffic over a year. But peak usage jumped 20-40% over a period of just four weeks during the lockdowns.

These numbers are beyond crazy. And it’s all because people have been working and entertaining themselves from home. Videoconferencing traffic – for both work and socializing – spiked 300%. Gaming traffic exploded 400%… because kids were staying home from school.

To put this growth in context, network data traffic would more than double every 12 months if this persists. We’re talking about exponential growth. And it’s overwhelming networks all over the world.

But not all technology investments will be winners in the years ahead.

In fact, investing in some companies right now could actually be dangerous. Some tech stocks have reached absurd valuations. And these are going to crash hard.

So today, I’ll show you two warning signs to look for when considering whether to invest in a tech stock…

Stodgy Old Darlings

Our first warning sign concerns tech stocks that some consider “darlings.” They’ve been around for decades and seem to be safe, solid investments.

But we shouldn’t let brand recognition trick us into investing in companies whose best days are behind them. Just because we’re familiar with a company’s products or logo doesn’t mean it’s stayed on the bleeding edge of progress.

To be successful in the tech sector, companies must be innovative. Their product strategy and road map are critical. And they must be improving people’s lives.

At one point, every successful tech company was an innovator. But some companies have simply lost the touch. They got buried in their past success and fell prey to unnecessary processes and groupthink.

Some Silicon Valley “old guards” are trying to profit off their reputations from 20 or even 40 years ago… But they will be a black hole for investments.

These companies may even look like good “value” plays right now. But they are dangerous investments.

In other words, there are far better places for you to put your money.


The Extra Income Project

Want the chance to put $2,500, $5,000, $10,000, or more in your pocket every Thursday?

Don’t Just Ask Me…SHOW ME!!!

Overhyped Tech Stocks

Our second warning sign is “hype.” Whenever we see news headlines blazing and hear chatter on social media, we should be careful to not get swept up in the current of excitement.

While public enthusiasm doesn’t disqualify a stock from being a good recommendation, many stocks either don’t deserve the attention they’ve received or have gotten so much attention that their numbers no longer make sense.

Right now, I see a lot of tech stocks trading at insanely high valuations… Valuations so high that even if these companies meet their aggressive growth assumptions, the stocks won’t rise much over the next five years. This future growth is already priced in. And if these companies see even one misstep or market downturn, the stocks will plummet.

Understanding a company’s valuation is the most important part of any investment. Even the best companies with technology none of their competitors have are not good investments if they’re trading at too high a valuation. Investing at an irrationally high valuation in a fantastic company will still lead to investment losses.

We can see the dangers of investing in overvalued technology companies by looking back at the dot-com bust of the late 1990s and early 2000s. Back then, companies were going public at absurd valuations with little more than a vague business plan and a “dot-com” in their name.

The founder and former CEO of Sun Microsystems, Scott McNealy, put it best. In an interview in 2000, he said:

We were selling at 10 times revenues […] At 10 times revenues, to give you a 10-year payback, I have to pay you 100% of revenues for 10 straight years in dividends.

That assumes I can get that by my shareholders. That assumes I have zero cost of goods sold, which is very hard for a computer company. That assumes zero expenses, which is really hard with 39,000 employees. That assumes I pay no taxes, which is very hard. And that assumes you pay no taxes on your dividends, which is kind of illegal. And that assumes with zero R&D for the next 10 years, I can maintain the current revenue run rate.

Now, having done that, would any of you like to buy my stock at $64? Do you realize how ridiculous those basic assumptions are? You don’t need any transparency. You don’t need any footnotes. What were you thinking?

As you can see in the chart below, Sun Microsystems peaked at $257 and plummeted 96% to $9.68.


Sun Microsystems’ fall didn’t happen because the company had bad technology. In fact, its Java programming language is still in use today. It fell because the valuation was way too high to support its future growth expectations.

I want to be very clear about one thing. I’m not suggesting that the technology market is poised for a broad collapse like we saw in the dot-com era.

Broadly speaking, many technology companies are much healthier than they were in the late ’90s. And the tech companies in the model portfolios of my research services are some of the best companies to own.

I retell this story to simply point out the dangers of investing in a company with an absurdly high valuation.

McNealy said an enterprise-value-to-sales (EV/sales) ratio of 10 was crazy high. I disagree with him on that. Some companies can justify an EV/sales ratio of 10 as long as they have the gross margins and growth rate to support it.

But now we see some large companies trading at an EV/sales ratio of 90! That’s an absurd valuation… and investors could lose most of their money if they hold on to these companies.

I want all my readers to be on the right side of market history.


The Wall Street Legend Who Picked Apple in 2003 and Bitcoin in 2016 – Shares #1 Pick for the 2020s


It’s not 5G, artificial intelligence, or the internet of things.

The answer will surprise you. And, for those who take early action, it could lead to an eventual $1.6 million payout.

See #1 Pick

It’s been my mission to help my readers avoid pitfalls like these overhyped, overvalued stocks… and find life-changing gains with companies that have the potential to become the next Amazon.

And I’ve recently discovered one promising area of the tech sector where these kinds of gains are still possible…

If you’re interested in learning more about a subset of small tech stocks that can spike hundreds or sometimes thousands of percent in just days, then I invite you to join me on September 23 at 8 p.m. ET. I’ve put together an urgent presentation that technology investors won’t want to miss.

In it, I’ll explain what these small tech stocks are, the reason they can be so explosive, and why we’re approaching a unique period that will send them into overdrive…

Jeff Brown’s First Ever Biotech Masterclass: Jeff Brown’s 1-Day Profits Summit

Claim Your FREE Spot for Jeff Brown’s First Ever Biotech Masterclass and Jeff Brown’s 1-Day Profits Summit. During The 1-Day Profits Summit Jeff Brown will release his new buy-alert with the name and ticker symbol of a small cap stock with the potential to soar.

When it comes to identifying disruptive technology, Silicon Valley insider Jeff Brown is one of the best analysts we know of.
With decades of experience, Jeff has an inside track on the biggest moneymaking opportunities in the space – before they hit front pages.

Jeff’s also an expert in the biotech space. So he’s been keeping tabs on the coronavirus pandemic since the start of the year.

In today’s essay, Jeff says the pandemic has accelerated this tech sector – and provided an opportunity for early investors to potentially make a fortune in 2020…

By Jeff Brown, editor, Early Stage Trader

It’s been a turbulent year for equity markets…

With the uncertainty around COVID-19, major U.S. indices experienced the worst crash in over a decade. The S&P 500 fell more than 33% in early spring. And even after a remarkable rally, the index is still down from its February high.

Other well-known businesses were not so lucky.

American Airlines, Carnival, and Hertz are down about 60%, 70%, and 91%, respectively, on the year. Hertz even filed for bankruptcy after more than 100 years in business.

With that sort of carnage, what I’m about to say next might sound shocking.

But the pandemic has actually accelerated certain industries. And investors in a few key stocks are making a fortune in 2020.

Here’s what I mean…


Why Everyone is Getting Rich Right Now … And You’re Not


Thousands of Americans have been hit by a wave of wealth in the wake of COVID-19. Stocks are up 40% since the crash, yet some lucky retirees have the opportunity to see 100%+ gains because of what’s coming next. How are they doing it?

For the first time in history, two millionaire investors have joined forces to help you learn the secret moneymaking strategy of the wealthy and connected.

Click here to watch their presentation

272% in Seven Months


That’s how much investors in Moderna (MRNA) have made since January. That’s right. Investors in this company have more than tripled their money in seven months. And this was during one of the worst pandemics in modern history.


How is this possible?

Well, as we likely know, Moderna is a biotechnology company focused on something called “synthetic biology.” That’s the technology that allows scientists to engineer functioning biological organisms.

For the most part, Moderna flew under the radar since the time of its initial public offering (IPO)… until the pandemic broke out. It’s using synthetic biology to create a vaccine for COVID-19.

Access Dark Market Insights – 24 Hour Trades exploding as Much as 1,360%+

It took the virus, sequenced it, and then designed a vaccine. It will hopefully produce immunity from COVID-19.

In a matter of days, Moderna came out as a leading candidate for a vaccine. And its stock price has more than tripled.

To see a synthetic biology company have a breakthrough like this shows why it’s one of the areas of biotech I’m most excited about over the next decade.


[ATTN] If You Own Any 5G Stocks, Or Are Considering Investing In 5G…

If you own any 5G stocks right now…

Or even if you’re considering investing in 5G…

There’s something you urgently need to know:

This new “5G Killer” technology  could make 5G obsolete…

Putting every 5G company out of business and sending 5G stocks crashing…

Click here for the urgent details.

COVID-19 Has Changed the Game for Biotechnology

I can’t emphasize enough how transformational this pandemic will be for the biotech industry. In the last 30 years, I’ve never seen the biotech industry come together and tackle a common problem as it has with COVID-19.

That’s everything from companies that produce diagnostics equipment to confirm whether somebody has COVID-19 – or has had COVID-19 – to all sorts of therapeutic approaches… to produce either a vaccine or a therapy for it.

That’s as well as evaluating existing drugs that have been used for decades to see if they can be repurposed in the pandemic.

It’s been extraordinary. And it’s shone a light on the biotech industry.

America’s #1 Stock Picker Reveals Next 1,000% Winner (free)

People didn’t realize how quickly the industry could move. Especially with the more advanced biotechnologies like synthetic biology and genetic engineering. These are being used to put potential candidates together in just a matter of months.

The process of drug discovery typically takes years. This is the first time we’ve seen that this can happen in months. In some cases, candidates were developed in a matter of days using modern techniques for drug discovery.

This has completely changed the game.

Because of how much progress has been made in such a short time, I predict we’re going to see record levels of investment in biotechnology.

That’s going to create even more exciting investment opportunities for people interested in this space.

But before you “throw a dart” at any biotech stock, there are a few things investors should know…


The #1 Tech Stock for 2020

Silicon Valley’s most successful investor,
Jeff Brown, will reveal why 266 million Americans
will buy this device by the end of the year.

To find out more, take a look at this video.

Understanding Biotech Investing

Few individual investors are familiar with this market. So there are a few things investors should know ahead of time…

For starters, some of the most exciting companies in this space are private.

I tend to track these companies from early on… sometimes as early as their seed venture capital (VC) round.

I follow their subsequent capital raises. And I keep a close eye on when I think the most exciting companies with the most exciting therapeutic approaches are going to go public.

There is a group of high-quality VC and private equity investors I track every week. They’re always good indicators of potentially exciting companies.

And there’s one more important rule about investing in the biotech markets…

Biotech Is Catalyst-Driven

Another important thing to know about this market is that biotechnology companies move on catalysts… on news.

That can be a presentation at a medical conference on September 20, at exactly 2 p.m. Pacific Standard Time. It can be at 4:30 p.m., on the East Coast, when a company announces its earnings.

The biotech industry lives and thrives off these specific moments in time. They are related to earnings calls… or papers they’re presenting at conferences… or filings with the FDA… or clinical trial results.

I’ll give you one example.

This company is Akero Therapeutics (AKRO). I recommended this stock to my readers in January.

This was a company I had been tracking closely even before its IPO. And I knew that Akero was on the verge of releasing clinical trial results for its Phase 2a clinical trial of AKR-001 in NASH patients.

Sure enough, the trial results were positive. The stock popped in June. We held on for a few more days and ultimately locked in gains of 87%.


Here’s what some of my readers had to say about the trade…

Hi, Jeff,

This is the first sell alert for me. I locked in gains of $6,600 in seven months. I am pleased with this…

I own all three of your services and am up $125,000 if I sold today. Thanks for your great advice and sharing your knowledge. I am looking forward to your new venture!

– Karen N.

(Gain of +$4,322.) I’m looking forward to the next moneymaker. Thanks much for your motivation to “help the little guy.”

– Frank S.

I’m pleased to inform you that this first trade has paid for my lifetime membership! I invested $5,016 and sold for $8,066.66. Now, let’s keep the momentum going!

– Dan S.

As great as this trade was, it’s actually on the lower side for our biotech trades. Last year, my readers locked in gains of 432% in under two months with Synthorx (THOR).

The important thing to understand is that investing in the right biotechs at the right time can lead to incredible gains in a matter of days or even hours.

And there is one biotech stock that is at the top of my list. If investors only ever invest in one biotechnology company, I believe it should be this one.

Based on my analysis, I believe this company is on the verge of a major announcement, a cure for a rare genetic disease. Once that happens, the stock will soar, possibly going as high as 1,000%.

To share all the details, I’m hosting my first-ever free biotechnology master class on August 5, at 8 p.m. ET. And I’d love it if readers could attend. Simply go right here to reserve your spot.

Dr. Steve Sjuggerud’s Project: Real Estate Event is June 24th at 8:00 p.m.

Dr. Steve Sjuggerud’s Project: Real Estate is taking place on Wednesday, June 24th at 8:00 p.m. where Steve will show you a brand-new kind of real estate investment opportunity that’s been off-limits to ordinary investors until recently.

If you’ve ever wanted to add more diversity, stability, and gain potential to your portfolio… by keeping some of your portfolio outside of the stock market — you won’t want to miss Dr. Steve Sjuggerud’s Project: Real Estate Event on June 24th.

Click Here To Get Dr. Steve Sjuggerud’s True Wealth Real Estate – Best Offer + Bonus Here

What is Dr. Steve Sjuggerud’s Project: Real Estate?

On June 24th, Dr. Sjuggerud will show you the real estate process he’s personally used to make himself and his family millions.

He’ll walk you through his own real estate investments, including homes he and his wife bought and flipped – tax certificates that paid him 18%… raw timberland—and everything in between.

“These are the crown jewels of my personal investment portfolio, and I can’t wait to share them with you.

Plus, with all that’s happening right now, the timing couldn’t be more perfect for you to get started investing in real estate, too.”

That’s because once you know what to look for,  real estate can be even more lucrative than stocks.

And it comes with almost NONE of the normal stress that comes from investing in the stock market.

During this event, Steve will even show you a brand-new kind of investment opportunity that’s been off-limits to ordinary investors until recently.

You can find out what this opportunity is and why Steve believes it’s the #1 best way to get started in real estate right now, once you sign up for his special broadcast on June 24th.

Click Here To Get Dr. Steve Sjuggerud’s True Wealth Real Estate – Best Offer + Bonus Here

Who Will Be Joining Stev at Dr. Steve Sjuggerud’s Project: Real Estate Event?

Joining him for this first-of-its-kind special will be Kendra Todd — the winner of Season 3 of the hit NBC show The Apprentice. Kendra managed one of Donald Trump’s high-end renovations that became the most expensive real estate transaction in the U.S. at the time.

Since then, she’s regularly appeared all over TV as a trusted name in real estate. And has been featured or quoted in ForbesUSA Today, and The Wall Street Journal.

She’ll be joining Steve on June 24th to share her unique insights with you.

You’ll also get the chance to hear from Ronan McMahon — one of the most well-connected international real estate gurus in the world.

Ronan McMahon is a global real estate scout. He spends six months of every year on the road, finding and negotiating opportunity to buy low and make serious profit from capital appreciation, rental income, or a mixture of both.

He’ll share some surprising boots-on-the-ground insight with you—including some of the most exciting international real estate opportunities today. Plus, there will be one more special guest, who will help Steve present to you an entirely new investment opportunity — one that few Americans even know exist.

Is Dr. Steve Sjuggerud’s Project: Real Estate Event Free To Attend?

Dr. Steve Sjuggerud’s Project: Real Estate Event is free to attend. You just enter your email address into the online form, and you’ll receive a link to the online event before June 24th.

When is Dr. Steve Sjuggerud’s Project: Real Estate Event?

Dr. Steve Sjuggerud’s Project: Real Estate is an online event scheduled for Wednesday, June 24 at 8pm EST. The event is hosted by Dr. Steve Sjuggerud. His guests will be Kendra Todd and Ronan McMahon.

Who is Dr. Steve Sjuggerud?

You know Dr. Steve Sjuggerud for his work on stocks. But the truth is, most of his personal investable net worth is OUTSIDE of the stock market.

And right now, Steve thinks the timing is perfect for you to do the same.

To show you what he meana, he’d like you to join his for the unveiling of his brand-new project on June 24th. Steve has built more wealth with this idea than any other investment you’ve seen him write about.

And he feels obligated to get this information in your hands at a time when you could benefit from it most.

Dr. Steve Sjuggerud’s Project: Real Estate – Final Word

After finishing your registration for Dr. Steve Sjuggerud’s Project: Real Estate Event on Wednesday, June 24th at 8:00 p.m. Eastern time, keep an eye on your inbox.

Specifically for messages from Project: Real Estate leading up to the big event – Dr. Sjuggerud will be sharing some exciting stories and opportunities from his personal experiences with real estate investments.

Click Here To Get Dr. Steve Sjuggerud’s True Wealth Real Estate – Best Offer + Bonus Here